FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896045248> ?p ?o ?g. }

• W2896045248 endingPage "345" @default.
• W2896045248 startingPage "339" @default.
• W2896045248 abstract "Recombinant activated factor VII (rFVIIa) concentrate reduces allogeneic blood transfusions, but it may increase thromboembolic complications in complex cardiac surgery. The mixture of activated factor VII (FVIIa) and factor X (FX) (FVIIa/FX) (FVIIa:FX = 1:10) is a novel bypassing agent for hemophilia patients. We hypothesized that the combination of FX and FVIIa could improve thrombin generation (TG) in acquired multifactorial coagulation defects such as seen in cardiac surgery and conducted in vitro evaluation of FVIIa/FX in parallel with other coagulation factor concentrates using in vitro and in vivo diluted plasma samples.Plasma samples were collected from 9 healthy volunteers and 12 cardiac surgical patients. We measured TG (Thrombinoscope) using in vitro 50% dilution plasma and in vivo dilution plasma after cardiopulmonary bypass, in parallel with thromboelastometry (ROTEM) and standard coagulation assays. In vitro additions of FVIIa/FX (0.35, 0.7, and 1.4 μg/mL, based on the FVIIa level), rFVIIa (1.4, 2.8, and 6.4 μg/mL), prothrombin complex concentrate (0.3 international unit), and 20% plasma replacement were evaluated.In diluted plasma, the addition of either FVIIa/FX or rFVIIa shortened the lag time and increased the peak TG, but the effect in lag time of FVIIa/FX at 0.35 μg/mL was more extensive than rFVIIa at 6.4 μg/mL. Prothrombin complex concentrate increased peak TG by increasing the prothrombin level but failed to shorten the lag time. No improvement in any of the TG variables was observed after 20% volume replacement with plasma. The addition of factor concentrates normalized prothrombin time/international normalized ratio but not with plasma replacement. In cardiac patients, similar patterns were observed on TG in post-cardiopulmonary bypass samples. FVIIa/FX shortened clotting time (CT) in a concentration-dependent manner on CT on thromboelastometry. Plasma replacement did not improve CT, but a combination of plasma and FVIIa/FX (0.35 μg/mL) more effectively shortened CT than FVIIa/FX alone.The combination of FVIIa and FX improved TG more efficiently than rFVIIa alone or plasma in dilutional coagulopathy models. The required FVIIa dose in FVIIa/FX was considerably lower than those reported during bypassing therapy in hemophilia patients (1.4-2.8 μg/mL). The combination of plasma could restore coagulation more efficiently compared to FVIIa/FX alone. Lesser FVIIa requirement to exert procoagulant activity may be favorable in terms of reducing systemic thromboembolic complications." @default.
• W2896045248 created "2018-10-26" @default.
• W2896045248 creator A5008806595 @default.
• W2896045248 creator A5012157258 @default.
• W2896045248 creator A5014356594 @default.
• W2896045248 creator A5031601538 @default.
• W2896045248 creator A5063237335 @default.
• W2896045248 creator A5063948660 @default.
• W2896045248 creator A5066866386 @default.
• W2896045248 creator A5081524743 @default.
• W2896045248 date "2019-08-01" @default.
• W2896045248 modified "2023-09-24" @default.
• W2896045248 title "Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy" @default.
• W2896045248 cites W1572873255 @default.
• W2896045248 cites W1819294471 @default.
• W2896045248 cites W1936413708 @default.
• W2896045248 cites W1964535328 @default.
• W2896045248 cites W1964625594 @default.
• W2896045248 cites W1972680096 @default.
• W2896045248 cites W1992288140 @default.
• W2896045248 cites W2009970055 @default.
• W2896045248 cites W2033421420 @default.
• W2896045248 cites W2034279285 @default.
• W2896045248 cites W2035589437 @default.
• W2896045248 cites W2035999342 @default.
• W2896045248 cites W2042994679 @default.
• W2896045248 cites W2063878434 @default.
• W2896045248 cites W2073752601 @default.
• W2896045248 cites W2095982855 @default.
• W2896045248 cites W2097594190 @default.
• W2896045248 cites W2100099564 @default.
• W2896045248 cites W2136797235 @default.
• W2896045248 cites W2139437745 @default.
• W2896045248 cites W2142456485 @default.
• W2896045248 cites W2146106384 @default.
• W2896045248 cites W2159149367 @default.
• W2896045248 cites W2257772822 @default.
• W2896045248 cites W2486128254 @default.
• W2896045248 cites W2521157042 @default.
• W2896045248 cites W2595445888 @default.
• W2896045248 cites W2725856287 @default.
• W2896045248 cites W2746755431 @default.
• W2896045248 cites W2780787960 @default.
• W2896045248 doi "https://doi.org/10.1213/ane.0000000000003858" @default.
• W2896045248 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30320649" @default.
• W2896045248 hasPublicationYear "2019" @default.
• W2896045248 type Work @default.
• W2896045248 sameAs 2896045248 @default.
• W2896045248 citedByCount "3" @default.
• W2896045248 countsByYear W28960452482022 @default.
• W2896045248 countsByYear W28960452482023 @default.
• W2896045248 crossrefType "journal-article" @default.
• W2896045248 hasAuthorship W2896045248A5008806595 @default.
• W2896045248 hasAuthorship W2896045248A5012157258 @default.
• W2896045248 hasAuthorship W2896045248A5014356594 @default.
• W2896045248 hasAuthorship W2896045248A5031601538 @default.
• W2896045248 hasAuthorship W2896045248A5063237335 @default.
• W2896045248 hasAuthorship W2896045248A5063948660 @default.
• W2896045248 hasAuthorship W2896045248A5066866386 @default.
• W2896045248 hasAuthorship W2896045248A5081524743 @default.
• W2896045248 hasBestOaLocation W28960452481 @default.
• W2896045248 hasConcept C126322002 @default.
• W2896045248 hasConcept C150903083 @default.
• W2896045248 hasConcept C207001950 @default.
• W2896045248 hasConcept C26809991 @default.
• W2896045248 hasConcept C2776301958 @default.
• W2896045248 hasConcept C2777091921 @default.
• W2896045248 hasConcept C2777292125 @default.
• W2896045248 hasConcept C2777444498 @default.
• W2896045248 hasConcept C2777664302 @default.
• W2896045248 hasConcept C2778382381 @default.
• W2896045248 hasConcept C2778881276 @default.
• W2896045248 hasConcept C2778961111 @default.
• W2896045248 hasConcept C2779161974 @default.
• W2896045248 hasConcept C2780434524 @default.
• W2896045248 hasConcept C2780930249 @default.
• W2896045248 hasConcept C42219234 @default.
• W2896045248 hasConcept C71924100 @default.
• W2896045248 hasConcept C86803240 @default.
• W2896045248 hasConcept C89560881 @default.
• W2896045248 hasConcept C98274493 @default.
• W2896045248 hasConceptScore W2896045248C126322002 @default.
• W2896045248 hasConceptScore W2896045248C150903083 @default.
• W2896045248 hasConceptScore W2896045248C207001950 @default.
• W2896045248 hasConceptScore W2896045248C26809991 @default.
• W2896045248 hasConceptScore W2896045248C2776301958 @default.
• W2896045248 hasConceptScore W2896045248C2777091921 @default.
• W2896045248 hasConceptScore W2896045248C2777292125 @default.
• W2896045248 hasConceptScore W2896045248C2777444498 @default.
• W2896045248 hasConceptScore W2896045248C2777664302 @default.
• W2896045248 hasConceptScore W2896045248C2778382381 @default.
• W2896045248 hasConceptScore W2896045248C2778881276 @default.
• W2896045248 hasConceptScore W2896045248C2778961111 @default.
• W2896045248 hasConceptScore W2896045248C2779161974 @default.
• W2896045248 hasConceptScore W2896045248C2780434524 @default.
• W2896045248 hasConceptScore W2896045248C2780930249 @default.
• W2896045248 hasConceptScore W2896045248C42219234 @default.
• W2896045248 hasConceptScore W2896045248C71924100 @default.

• next